• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

miR-205 通过靶向 PTEN 促进 NSCLC 细胞的生长、转移和化疗耐药性。

miR-205 promotes the growth, metastasis and chemoresistance of NSCLC cells by targeting PTEN.

机构信息

Department of Oncology, Xiangyang Central Hospital, Xiangyang 441021, P.R. China.

出版信息

Oncol Rep. 2013 Dec;30(6):2897-902. doi: 10.3892/or.2013.2755. Epub 2013 Sep 30.

DOI:10.3892/or.2013.2755
PMID:24084898
Abstract

Non-small cell lung cancer (NSCLC) is one of the most common causes of cancer-related mortality worldwide. microRNAs (miRNAs) play critical roles in carcinogenesis. miR-205 has been shown to be upregulated in NSCLC. In the present study, we identified the promotive effects of miR-205 on various significant biological properties of NSCLC cells, and confirmed the regulation of PTEN by miR-205. The expression of miR-205 was examined by quantitative real-time PCR both in NSCLC cell lines and tissues. The effect of miR-205 on PTEN expression was assessed in NSCLC cell lines with miR-205 mimics/inhibitor to elevate/decrease miR-205 expression. Furthermore, the roles of miR-205 in regulating the biological properties of NSCLC cells, including growth, invasion and chemoresistance, were assayed using miR-205 mimic/inhibitor-transfected cells. The 3'-untranslated region (3'-UTR) of PTEN combined with miR-205 and this was confirmed by luciferase reporter assay and western blotting. miR-205 expression was increased in NSCLC cell lines as well as in tissues. Overexpression of miR-205 promoted growth, migration and invasion, and enhanced the chemoresistance of NSCLC cells. Luciferase activity and western blotting demonstrated that miR-205 negatively regulated PTEN at a posttranscriptional level. However, miR-205 knockdown suppressed these processes in A549 cells and increased the expression of PTEN protein. Furthermore, overexpression of PTEN exhibited effects identical with those of the miR-205 inhibitor in NSCLC cells. Our results demonstrated that miR-205 is involved in the tumorigenesis of NSCLC through modulation of the PTEN signaling pathway.

摘要

非小细胞肺癌(NSCLC)是全球癌症相关死亡的最常见原因之一。microRNAs(miRNAs)在癌症发生中起关键作用。miR-205 在 NSCLC 中被证明上调。在本研究中,我们确定了 miR-205 对 NSCLC 细胞各种重要生物学特性的促进作用,并证实了 miR-205 对 PTEN 的调节作用。通过定量实时 PCR 检测 NSCLC 细胞系和组织中 miR-205 的表达。通过 miR-205 模拟物/抑制剂在 NSCLC 细胞系中上调/下调 miR-205 表达,评估 miR-205 对 PTEN 表达的影响。此外,通过 miR-205 模拟物/抑制剂转染细胞,检测 miR-205 在调节 NSCLC 细胞生物学特性(包括生长、侵袭和化疗耐药性)中的作用。PTEN 的 3'-非翻译区(3'-UTR)与 miR-205 结合,并通过荧光素酶报告基因检测和 Western blot 证实。miR-205 在 NSCLC 细胞系和组织中表达增加。miR-205 的过表达促进了 NSCLC 细胞的生长、迁移和侵袭,并增强了其化疗耐药性。荧光素酶活性和 Western blot 表明,miR-205 在转录后水平负调控 PTEN。然而,miR-205 敲低抑制了 A549 细胞中的这些过程,并增加了 PTEN 蛋白的表达。此外,PTEN 的过表达在 NSCLC 细胞中表现出与 miR-205 抑制剂相同的作用。我们的研究结果表明,miR-205 通过调节 PTEN 信号通路参与 NSCLC 的肿瘤发生。

相似文献

1
miR-205 promotes the growth, metastasis and chemoresistance of NSCLC cells by targeting PTEN.miR-205 通过靶向 PTEN 促进 NSCLC 细胞的生长、转移和化疗耐药性。
Oncol Rep. 2013 Dec;30(6):2897-902. doi: 10.3892/or.2013.2755. Epub 2013 Sep 30.
2
MicroRNA-92a promotes growth, metastasis, and chemoresistance in non-small cell lung cancer cells by targeting PTEN.微小RNA-92a通过靶向PTEN促进非小细胞肺癌细胞的生长、转移和化疗耐药性。
Tumour Biol. 2016 Mar;37(3):3215-25. doi: 10.1007/s13277-015-4150-3. Epub 2015 Oct 2.
3
miR-106a promotes growth and metastasis of non-small cell lung cancer by targeting PTEN.微小RNA-106a通过靶向磷酸酶和张力蛋白同源物促进非小细胞肺癌的生长和转移。
Int J Clin Exp Pathol. 2015 Apr 1;8(4):3827-34. eCollection 2015.
4
MicroRNA-21 (miR-21) represses tumor suppressor PTEN and promotes growth and invasion in non-small cell lung cancer (NSCLC).微小 RNA-21(miR-21)抑制肿瘤抑制因子 PTEN,促进非小细胞肺癌(NSCLC)的生长和侵袭。
Clin Chim Acta. 2010 Jun 3;411(11-12):846-52. doi: 10.1016/j.cca.2010.02.074. Epub 2010 Mar 16.
5
MicroRNA-21 (miR-21) expression promotes growth, metastasis, and chemo- or radioresistance in non-small cell lung cancer cells by targeting PTEN.微小 RNA-21(miR-21)通过靶向 PTEN 促进非小细胞肺癌细胞的生长、转移以及化疗或放疗耐药性。
Mol Cell Biochem. 2013 Jan;372(1-2):35-45. doi: 10.1007/s11010-012-1443-3. Epub 2012 Sep 6.
6
MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis.微小 RNA-92a 通过激活 PTEN/PI3K/AKT 信号通路促进非小细胞肺癌转移中的上皮-间充质转化。
Int J Oncol. 2017 Jul;51(1):235-244. doi: 10.3892/ijo.2017.3999. Epub 2017 May 16.
7
miR-543 is up-regulated in gefitinib-resistant non-small cell lung cancer and promotes cell proliferation and invasion via phosphatase and tensin homolog.miR-543在吉非替尼耐药的非小细胞肺癌中上调,并通过磷酸酶和张力蛋白同源物促进细胞增殖和侵袭。
Biochem Biophys Res Commun. 2016 Nov 18;480(3):369-374. doi: 10.1016/j.bbrc.2016.10.055. Epub 2016 Oct 18.
8
Downregulation of microRNA-193-3p inhibits tumor proliferation migration and chemoresistance in human gastric cancer by regulating PTEN gene.微小RNA-193-3p的下调通过调控PTEN基因抑制人胃癌的肿瘤增殖、迁移和化疗耐药性。
Tumour Biol. 2016 Jul;37(7):8941-9. doi: 10.1007/s13277-015-4727-x. Epub 2016 Jan 11.
9
Deregulation of lncRNA-AC078883.3 and microRNA-19a is involved in the development of chemoresistance to cisplatin via modulating signaling pathway of PTEN/AKT.lncRNA-AC078883.3 和 microRNA-19a 的失调通过调节 PTEN/AKT 信号通路参与顺铂化疗耐药的发生。
J Cell Physiol. 2019 Dec;234(12):22657-22665. doi: 10.1002/jcp.28832. Epub 2019 May 20.
10
E2F1-Induced Overexpression of Long Noncoding RNA SBF2-AS1 Promotes Non-Small-Cell Lung Cancer Metastasis Through Regulating miR-362-3p/GRB2 Axis.E2F1 诱导的长链非编码 RNA SBF2-AS1 过表达通过调节 miR-362-3p/GRB2 轴促进非小细胞肺癌转移。
DNA Cell Biol. 2020 Jul;39(7):1290-1298. doi: 10.1089/dna.2020.5426. Epub 2020 May 4.

引用本文的文献

1
A comprehensive in silico analysis and experimental validation of miRNAs capable of discriminating between lung adenocarcinoma and squamous cell carcinoma.能够区分肺腺癌和肺鳞状细胞癌的microRNA的全面计算机分析及实验验证。
Front Genet. 2024 Sep 23;15:1419099. doi: 10.3389/fgene.2024.1419099. eCollection 2024.
2
Loss of Key EMT-Regulating miRNAs Highlight the Role of ZEB1 in EGFR Tyrosine Kinase Inhibitor-Resistant NSCLC.关键 EMT 调节 miRNA 的丢失凸显了 ZEB1 在 EGFR 酪氨酸激酶抑制剂耐药 NSCLC 中的作用。
Int J Mol Sci. 2023 Sep 29;24(19):14742. doi: 10.3390/ijms241914742.
3
- Enhances Cisplatin Sensitivity via Decreasing SATB2 Expression in Lung Adenocarcinoma.
增强 SATB2 表达对肺腺癌顺铂敏感性的作用。
Genes (Basel). 2023 Apr 14;14(4):911. doi: 10.3390/genes14040911.
4
Cell cycle associated miRNAs as target and therapeutics in lung cancer treatment.细胞周期相关的微小RNA作为肺癌治疗的靶点和疗法
Heliyon. 2022 Oct 13;8(10):e11081. doi: 10.1016/j.heliyon.2022.e11081. eCollection 2022 Oct.
5
microRNA-205 in prostate cancer: Overview to clinical translation.微小 RNA-205 在前列腺癌中的作用:从临床前研究到临床转化。
Biochim Biophys Acta Rev Cancer. 2022 Nov;1877(6):188809. doi: 10.1016/j.bbcan.2022.188809. Epub 2022 Oct 1.
6
MicroRNA Signatures in the Upper Urinary Tract Urothelial Carcinoma Scenario: Ready for the Game Changer?上尿路尿路上皮癌中的 microRNA 特征:准备好改变游戏规则了吗?
Int J Mol Sci. 2022 Feb 26;23(5):2602. doi: 10.3390/ijms23052602.
7
The Roles of microRNAs in Cancer Multidrug Resistance.微小RNA在癌症多药耐药中的作用
Cancers (Basel). 2022 Feb 21;14(4):1090. doi: 10.3390/cancers14041090.
8
Hsa-miR-335 enhances cell migration and invasion in lung adenocarcinoma through targeting Copine-1.人源微小RNA-335通过靶向结合1型柯平蛋白增强肺腺癌细胞的迁移和侵袭能力。
MedComm (2020). 2021 Nov 4;2(4):810-820. doi: 10.1002/mco2.93. eCollection 2021 Dec.
9
Exosomal miRNA-205 promotes breast cancer chemoresistance and tumorigenesis through E2F1.外泌体 miRNA-205 通过 E2F1 促进乳腺癌化疗耐药和肿瘤发生。
Aging (Albany NY). 2021 Jul 22;13(14):18498-18514. doi: 10.18632/aging.203298.
10
MicroRNA Therapeutics in Cancer: Current Advances and Challenges.癌症中的微小RNA疗法:当前进展与挑战
Cancers (Basel). 2021 May 29;13(11):2680. doi: 10.3390/cancers13112680.